Specialty Pharmacy

Research highlights the need for new prostate specific antigen testing guidelines.

Ozanimod evaluated as a treatment for multiple sclerosis and inflammatory bowel disease.

Men exposed to diesel exhaust at work may increase their risk of ALS by at least 20%.

Top news of the day from across the health care landscape.

PBMs currently operate in Arkansas with no government oversight

ZTlido (lidocaine topical system) shows superior adhesion compared with other topical non-opioid pain patches.

Accounting for potential drug resistance improve the treatment of cancer.

Amazon, Berkshire Hathaway, JP Morgan Chase partnership seeks to revolutionize health care.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks about the many considerations that have to be addressed when launching a novel rare disease drug in a specialty-naive market.

Specialty pharmacies must focus on the fundamentals of compassion and effective communication to offer the patient-centric support needed for patients with a rare disease.

Several new approaches may increase drug development efforts for rare diseases.

The data published analyzes findings from key studies evaluating taliglucerase alfa in patients with Gaucher disease.

Top news of the day from across the health care landscape.

The National Comprehensive Cancer Network seeks to address issues related to treating HIV-positive patients with cancer, such as the potential for drug interactions.

Pharmacists can submit photos and captions to be featured on social media.

Medicaid spending on specialty drugs is a top concern for states.

Benefits of fish oils may be reduced in obese patients due to high inflammation levels.

Number of days spent depressed resulted in higher mortality rates among patients with HIV.

Targeting all adults for hepatitis C virus testing may identify more cases and improve cure rates.

Increasing exercise levels may reduce the risk of several cancers.

Top news of the day from across the health care landscape.

The FDA previously approved abemaciclib for use in combination with fulvestrant in women with HR+/HER2- advanced breast cancer with disease progression following endocrine therapy.

The standardization of value-based models is crucial as they become widely-adopted.

Mike Agostino, RPh, President, National Association of Specialty Pharmacy, reflects on how the organization advances the specialty pharmacy industry through their annual meeting.

The gut microbiome may play a key role impact the severity of multiple sclerosis symptoms.

The sixth annual National Association of Specialty Pharmacy meeting features numerous educational sessions and networking opportunities for specialty pharmacy stakeholders.

Patients with cancer experienced a reduction in fatigue after 3 weeks of knowingly taking a placebo.

Some patients may be unwilling to undergo traditional screening for cervical cancer.

Top news of the day from across the health care landscape.

GDC-0084 is a small molecule inhibitor of phosphatidylinositol 3-kinase with potential antineoplastic activity.